Successful treatment of aortic dissection during sorafenib therapy for hepatocellular carcinoma

Clinical Case Reports
Atsunori TsuchiyaShuji Terai

Abstract

Our case highlights the need for caution during vascular endothelial growth factor pathway inhibitor (VPI) therapy and for the occurrence of aortic dissection. If Stanford classification type A aortic dissection occurs during VPI therapy, surgical intervention should be considered to prevent cardiac tamponade if the patient's clinical condition permits it.

References

Oct 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C SerranoJ Carles

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

Clinics and Research in Hepatology and Gastroenterology
Lin XuWei Ding
The Journal of Emergency Medicine
Fabio Fernandes NevesValdair F Muglia
JACC. Cardiovascular Interventions
Ivo PetrovPlamen Stanilov
© 2022 Meta ULC. All rights reserved